Compatibility of Different Formulations in Pentravan<sup>®</sup> and Pentravan<sup>®</sup> Plus for Transdermal Drug Delivery
The potential therapeutic benefit of transdermal delivery systems for some active pharmaceutical ingredients (APIs) has been well-established for decades within the scientific community. However, together with the clinical efficacy, there is the need for an evaluation of the stability of such APIs i...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2021-11-01
|
| Edice: | Scientia Pharmaceutica |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2218-0532/89/4/51 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|